Interleukin 1 beta gene promoter SNPs are associated with risk of pancreatic cancer

Cytokine

Volumn 46, Issue 2, 2009, Pages 182-186

  Hamacher, Rainer ^a   Diersch, Sandra ^a   Scheibel, Melanie ^a   Eckel, Florian ^a   Mayr, Martina ^a   Rad, Roland ^a   Bajbouj, Monther ^a   Schmid, Roland M ^a   Saur, Dieter ^a   Schneider, Günter ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Inflammation; Interleukin 1 beta; Pancreatic cancer; SNP

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL LINE, TUMOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 65049086188     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.01.005     Document Type: Article

References (41)

1. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow? Lancet 357 (2001) 539-545
2. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
3. Farrow B., and Evers B.M. Inflammation and the development of pancreatic cancer. Surg Oncol 10 (2002) 153-169
4. Algul H., Treiber M., Lesina M., and Schmid R.M. Mechanisms of disease: chronic inflammation and cancer in the pancreas a potential role for pancreatic stellate cells?. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 454-462
5. Lowenfels A.B., Maisonneuve P., Cavallini G., Ammann R.W., Lankisch P.G., Andersen J.R., et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 328 (1993) 1433-1437
6. Lowenfels A.B., Maisonneuve P., DiMagno E.P., Elitsur Y., Gates Jr. L.K., Perrault J., et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89 (1997) 442-446
7. Malka D., Hammel P., Maire F., Rufat P., Madeira I., Pessione F., et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 51 (2002) 849-852
8. Guerra C., Schuhmacher A.J., Canamero M., Grippo P.J., Verdaguer L., Perez-Gallego L., et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11 (2007) 291-302
9. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
10. Apte R.N., Dotan S., Elkabets M., White M.R., Reich E., Carmi Y., et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25 (2006) 387-408
11. Apte R.N., and Voronov E. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?. Immunol Rev 222 (2008) 222-241
12. Tu S., Bhagat G., Cui G., Takaishi S., Kurt-Jones E.A., Rickman B., et al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14 (2008) 408-419
13. Ebrahimi B., Tucker S.L., Li D., Abbruzzese J.L., and Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 101 (2004) 2727-2736
14. Muerkoster S., Wegehenkel K., Arlt A., Witt M., Sipos B., Kruse M.L.., et al. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 64 (2004) 1331-1337
15. Stefani A.L., Basso D., Panozzo M.P., Greco E., Mazza S., Zancanaro F., et al. Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. Pancreas 19 (1999) 362-369
16. Greco E., Basso D., Fogar P., Mazza S., Navaglia F., Zambon C.F., et al. Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1. Int J Biol Markers 20 (2005) 235-241
17. ten Kate M., Hofland L.J., van Koetsveld P.M., Jeekel J., and van Eijck C.H. Pro-inflammatory cytokines affect pancreatic carcinoma cell. Endothelial Cell Interact 7 (2006) 454-464
18. Arlt A., Vorndamm J., Muerkoster S., Yu H., Schmidt W.E., Folsch U.R., et al. Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res 62 (2002) 910-916
19. Angst E., Reber H.A., Hines O.J., and Eibl G. Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. Surgery 144 (2008) 57-65
20. di Giovine F.S., Takhsh E., Blakemore A.I., and Duff G.W. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1 (1992) 450
21. Pociot F., Molvig J., Wogensen L., Worsaae H., and Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 22 (1992) 396-402
22. Guasch J.F., Bertina R.M., and Reitsma P.H. Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. Cytokine 8 (1996) 598-602
23. Chen H., Wilkins L.M., Aziz N., Cannings C., Wyllie D.H., Bingle C., et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15 (2006) 519-529
24. Haukim N., Bidwell J.L., Smith A.J., Keen L.J., Gallagher G., Kimberly R., et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun 3 (2002) 313-330
25. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
26. Ito L.S., Iwata H., Hamajima N., Saito T., Matsuo K., Mizutani M., et al. Significant reduction in breast cancer risk for Japanese women with interleukin 1B -31 CT/TT relative to CC genotype. Jpn J Clin Oncol 32 (2002) 398-402
27. Wang Y., Kato N., Hoshida Y., Yoshida H., Taniguchi H., Goto T., et al. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37 (2003) 65-71
28. Zienolddiny S., Ryberg D., Maggini V., Skaug V., Canzian F., and Haugen A. Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 109 (2004) 353-356
29. Barber M.D., Powell J.J., Lynch S.F., Fearon K.C., and Ross J.A. A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br J Cancer 83 (2000) 1443-1447
30. Sobin L.H., and Wittekind C. TNM Classification of Malignant Tumors (2002), Wiley, New York
31. Retzer-Lidl M., Schmid R.M., and Schneider G. Inhibition of CDK4 impairs proliferation of pancreatic cancer cells and sensitizes towards TRAIL-induced apoptosis via downregulation of surviving. Int J Cancer 121 (2007) 66-75
32. Machado J.C., Pharoah P., Sousa S., Carvalho R., Oliveira C., Figueiredo C., et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121 (2001) 823-829
33. Yang G.F., Luo J., Wu H.W., Li P., and Xiong Y.Y. Interleukin-1 gene family polymorphisms from paraffin-embedded archival tissue of Chinese patients with gastric ulcer and gastric cancer. Hepatogastroenterology 55 (2008) 1878-1881
34. Lind H., Haugen A., and Zienolddiny S. Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells. Cytokine 38 (2007) 43-48
35. Rogus J., Beck J.D., Offenbacher S., Huttner K., Iacoviello L., Latella M.C., et al. IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein. Hum Genet 123 (2008) 387-398
36. Zhang Y., and Rom W.N. Regulation of the interleukin-1 beta (IL-1 beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs. Mol Cell Biol 13 (1993) 3831-3837
37. Toda Y., Tsukada J., Misago M., Kominato Y., Auron P.E., and Tanaka Y. Autocrine induction of the human pro-IL-1beta gene promoter by IL-1beta in monocytes. J Immunol 168 (2002) 1984-1991
38. Mouri F., Tsukada J., Mizobe T., Higashi T., Yoshida Y., Minami Y., et al. Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1. Eur J Haematol 80 (2008) 10-19
39. Santtila S., Savinainen K., and Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47 (1998) 195-198
40. Rad R., Dossumbekova A., Neu B., Lang R., Bauer S., Saur D., et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53 (2004) 1082-1089
41. Rad R., Prinz C., Neu B., Neuhofer M., Zeitner M., Voland P., et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 188 (2003) 272-281